The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
An endocannabinoid mechanism for stress-induced analgesia
Open accessAbstract
Acute stress suppresses pain by activating brain pathways that engage opioid or non-opioid mechanisms. Here we show that an opioid-independent form of this phenomenon, termed stress-induced analgesia, is mediated by the release of endogenous marijuana-like (cannabinoid) compounds in the brain. Blockade of cannabinoid CB(1) receptors in the periaqueductal grey matter of the midbrain prevents non-opioid stress-induced analgesia. In this region, stress elicits the rapid formation of two endogenous cannabinoids, the lipids 2-arachidonoylglycerol (2-AG) and anandamide. A newly developed inhibitor of the 2-AG-deactivating enzyme, monoacylglycerol lipase, selectively increases 2-AG concentrations and, when injected into the periaqueductal grey matter, enhances stress-induced analgesia in a CB1-dependent manner. Inhibitors of the anandamide-deactivating enzyme fatty-acid amide hydrolase, which selectively elevate anandamide concentrations, exert similar effects. Our results indicate that the coordinated release of 2-AG and anandamide in the periaqueductal grey matter might mediate opioid-independent stress-induced analgesia. These studies also identify monoacylglycerol lipase as a previously unrecognized therapeutic target.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Monoacylglycerol lipase (MGL) is a key enzyme implicated in the hydrolysis of 2-AG.33, 34”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [33]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Self-citationImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Self-citationBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Self-citationIncreased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Self-citation
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Walker, J. M. & Hohmann, A. G. in Cannabinoids—Handbook of Experimental Pharmacology (ed. Pertwee, R.) 509–554 (Springer, Berlin, 2005)
Cited by
Sorted by citations
Items 301–400 of 795
Bassi, M. S., Gilio, L., Maffei, P., Dolcetti, E., Bruno, A., Buttari, F., Centonze, D., & Iezzi, E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00424 · Cited by 51
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study
Greco, R., Demartini, C., Zanaboni, A. M., Tumelero, E., Reggiani, A. M., Misto, A., Piomelli, D., & Tassorelli, C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104624 · Cited by 50
Self-citationTHC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Pintori, N., Caria, F., Luca, M. A. D., & Miliano, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065251 · Cited by 50
2-Arachidonoylglycerol (2-AG) Membrane Transport: History and Outlook
Hermann, A., Kaczocha, M., & Deutsch, D. G. (2006) · The AAPS Journal · doi:10.1007/bf02854913 · Cited by 47
Yu, G., Ying, Y.-L., Wang, B., Mo, L., & Zhang, Z. (2025) · Journal of Catalysis · doi:10.1016/j.jcat.2025.115938 · Cited by 46
Mitchell, V. A., Jeong, H., Drew, G. M., & Vaughan, C. W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.59 · Cited by 46
Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors
Minkkilä, A., Saario, S. M., & Nevalainen, T. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791164238 · Cited by 46
Cristino, L., Luongo, L., Imperatore, R., Boccella, S., Becker, T., Morello, G., Piscitelli, F., Busetto, G., Maione, S., & Marzo, V. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.173 · Cited by 45
The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review
Fowler, C. J. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_4 · Cited by 46
Seillier, A., Aguilar, D. D., & Giuffrida, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.022 · Cited by 45
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
Appiah‐Kusi, E., Leyden, E., Parmar, S. R., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2015) · Psychological Medicine · doi:10.1017/s0033291715001786 · Cited by 46
Vacondio, F., Silva, C., Lodola, A., Fioni, A., Rivara, S., Duranti, A., Tontini, A., Sanchini, S., Clapper, J. R., Piomelli, D., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900120 · Cited by 45
Self-citationStressed-out endogenous cannabinoids relieve pain
Vaughan, C. W. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.011 · Cited by 44
Burston, J. J., Sim‐Selley, L. J., Harloe, J. P., Mahadevan, A., Razdan, R. K., Selley, D. E., & Wiley, J. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141382 · Cited by 44
Stress and pain: modality-specific opioid mediation of stress-induced analgesia
Al’Absi, M., Nakajima, M., & Bruehl, S. P. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02401-4 · Cited by 43
Ang, S. P., Sidharthan, S., Lai, W. C., Hussain, N., Patel, K. V., Gulati, A., Henry, O., Kaye, A. D., & Orhurhu, V. (2023) · Pain and Therapy · doi:10.1007/s40122-022-00465-y · Cited by 43
Aizawa, N., Hedlund, P., Füllhase, C., Ito, H., Homma, Y., & Igawa, Y. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.04.008 · Cited by 43
Chemical modulation of glycerolipid signaling and metabolic pathways
Scott, S., Mathews, T. P., Ivanova, P. T., Lindsley, C. W., & Brown, H. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.009 · Cited by 44
Magerl, W., Burkart, D., Fernandez, A., Schmidt, L., & Treede, R. (2011) · Pain · doi:10.1016/j.pain.2011.11.021 · Cited by 48
Nicotinic modulation of descending pain control circuitry
Umana, I. C., Daniele, C. A., Miller, B. A., Abburi, C., Gallagher, K., Brown, M. A., Mason, P., & McGehee, D. S. (2017) · Pain · doi:10.1097/j.pain.0000000000000993 · Cited by 43
Amini-Khoei, H., Amiri, S., Mohammadi‐Asl, A., Alijanpour, S., Poursaman, S., Haj‐Mirzaian, A., Rastegar, M., Mesdaghinia, A., Banafshe, H. R., Sadeghi, E., et al. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.11.005 · Cited by 43
Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence
Célèrier, E., Ahdepil, T., Wikander, H., Berrendero, F., Nyberg, F., & Maldonado, R. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.017 · Cited by 43
Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010) · PubMed · Cited by 43
Monoglyceride Lipase as an Enzyme Hydrolyzing 2‐Arachidonoylglycerol
Saario, S. M., & Laitinen, J. T. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790158 · Cited by 43
Kaufmann, I., Hauer, D., Huge, V., Vogeser, M., Campolongo, P., Choukèr, A., Thiel, M., & Schelling, G. (2009) · European Surgical Research · doi:10.1159/000235870 · Cited by 43
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats
McReynolds, J. R., Doncheck, E. M., Vranjkovic, O., Ganzman, G. S., Baker, D. L., Hillard, C. J., & Mantsch, J. R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4092-x · Cited by 42
Ren, K., & Dubner, R. A. (2008) · Elsevier eBooks · doi:10.1016/b978-012370880-9.00192-4 · Cited by 44
New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors
Gertsch, J., Raduner, S., & Altmann, K. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600942674 · Cited by 42
Martins, D. F., Mazzardo‐Martins, L., Cidral‐Filho, F. J., Gadotti, V. M., & Santos, A. R. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.055 · Cited by 42
Almeida-Santos, A. F., Gobira, P. H., Rosa, L. C., Guimaraes, F. S., Moreira, F. A., & Aguiar, D. C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.027 · Cited by 41
Rea, K., Olango, W. M., Harhen, B., Kerr, D. M., Galligan, R., Fitzgerald, S. T., Moore, M., Roche, M., & Finn, D. P. (2012) · Pain · doi:10.1016/j.pain.2012.12.021 · Cited by 41
Mangieri, R. A., Hong, K., Piomelli, D., & Sinha, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1518-3 · Cited by 43
Self-citationInhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice
Cavener, V. S., Gaulden, A. D., Pennipede, D., Jagasia, P., Uddin, J., Marnett, L. J., & Patel, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00479 · Cited by 43
Dotsey, E. Y., Jung, K., Basit, A., Don, W., Daglian, J. M., Vacondio, F., Armirotti, A., Mor, M., & Piomelli, D. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.04.013 · Cited by 42
Self-citationDon, W., Lee, D., Li, D., Daglian, J. M., Jung, K., & Piomelli, D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4222-0 · Cited by 44
Self-citationEstimating Time of Last Oral Ingestion of Cannabis From Plasma THC and THCCOOH Concentrations
Huestis, M. A., ElSohly, M. A., Nebro, W., Barnes, A. J., Gustafson, R. A., & Smith, M. L. (2006) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200608000-00009 · Cited by 40
Endocannabinoid signaling in neurotoxicity and neuroprotection
Pope, C., Mechoulam, R., & Parsons, L. H. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.12.002 · Cited by 40
Physiological roles of 2‐arachidonoylglycerol, an endogenous cannabinoid receptor ligand
Sugiura, T. (2009) · BioFactors · doi:10.1002/biof.18 · Cited by 40
Lau, B. K., & Vaughan, C. W. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045872 · Cited by 42
Gowatch, L. C., Evanski, J. M., Ely, S. L., Zundel, C. G., Bhogal, A., Carpenter, C., Shampine, M. M., O’Mara, E., Mazurka, R., Barcelona, J., et al. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0246 · Cited by 39
Khasabova, I. A., Uhelski, M. L., Khasabov, S. G., Gupta, K., Seybold, V. S., & Simone, D. A. (2019) · Blood · doi:10.1182/blood-2018-11-884346 · Cited by 39
Uddin, M. S., Mamun, A. A., Sumsuzzman, D. M., Ashraf, G. M., Perveen, A., BUNGAU, S. G., Mousa, S. A., El-Seedi, H. R., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01097 · Cited by 39
Nakamoto, K., & Tokuyama, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411713 · Cited by 41
Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 39
The critical role of spinal 5-HT7 receptors in opioid and non-opioid type stress-induced analgesia
Yeşilyurt, Ö., Seyrek, M., Taşdemir, S., Kahraman, S., Deveci, M. S., Karakuş, E., Halıcı, Z., & Dogrul, A. B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.020 · Cited by 38
Novoseletsky, N., NUSSINOVITCH, A., & Friedman‐Einat, M. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.11.011 · Cited by 38
García, M. D. C., Adler‐Graschinsky, E., & Celuch, S. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.021 · Cited by 38
Batista, L. A., Gobira, P. H., Viana, T. G., de Aguiar, D. C., & Moreira, F. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000073 · Cited by 38
The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
Ramer, R., Wittig, F., & Hinz, B. (2021) · Cancers · doi:10.3390/cancers13225701 · Cited by 39
Schmidt, W., Schäfer, F., Striggow, V., Fröhlich, K., & Striggow, F. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.080 · Cited by 39
Rojas, M. J. L., Galeano, P., Suárez, J., Araos, P. F., Santín, L. J., de Fonseca, F. R., & Blanco, E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000569 · Cited by 38
Douglas, J. M., Guzman, D. S.-M., & Paul‐Murphy, J. (2017) · Veterinary Clinics of North America Exotic Animal Practice · doi:10.1016/j.cvex.2017.08.008 · Cited by 38
Armirotti, A., Romeo, E., Ponzano, S., Mengatto, L., Dionisi, M., Karacsonyi, C., Bertozzi, F., Garau, G., Tarozzo, G., Reggiani, A. M., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300056y · Cited by 37
Self-citationGorzalka, B. B., & Hill, M. N. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_12 · Cited by 38
Development of highly sensitive fluorescent assays for fatty acid amide hydrolase
Huang, H., Nishi, K., Tsai, H.-J., & Hammock, B. D. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.041 · Cited by 38
The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
Guindon, J., & Beaulieu, P. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010134 · Cited by 37
Haghparast, A., Ghalandari-Shamami, M., & Hassanpour-Ezatti, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.023 · Cited by 36
Ostadhadi, S., Haj‐Mirzaian, A., Nikoui, V., Kordjazy, N., & Dehpour, A. R. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12518 · Cited by 36
Reddy, S. T., Krovi, K. P., & Swamy, M. J. (2014) · Crystal Growth & Design · doi:10.1021/cg500481u · Cited by 36
Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits
Copits, B. A., Pullen, M. Y., & Gereau, R. W. (2016) · Pain · doi:10.1097/j.pain.0000000000000620 · Cited by 37
Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37
Yin, J.-B., Wu, H., Dong, Y., Zhang, T., Wang, J., Zhang, Y., Wei, Y., Lu, Y.-C., Wu, S., Wang, W., et al. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00137 · Cited by 38
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice
Carey, L. M., Gutierrez, T., Deng, L., Lee, W.-H., Mackie, K., & Hohmann, A. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01062-2 · Cited by 35
Self-citationGiuffrida, A., & McMahon, L. R. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.004 · Cited by 40
Genro, B. P., Alvares, L. D. O., & Quillfeldt, J. A. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.01.002 · Cited by 35
Shen, S., Wu, C., Lin, G., Yang, X., Zhou, Y., Zhao, C. S., Miao, Z., Tian, X., Wang, K., Yang, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321532121 · Cited by 34
da Silva, J. A., Biagioni, A. F., Almada, R. C., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., & Coimbra, N. C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.051 · Cited by 34
Yang, N. J., Isensee, J., Neel, D. V., de Quadros, A. U., Zhang, H.-X. B., Lauzadis, J., Liu, S. M., Shiers, S. I., Belu, A., Palan, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00973-8 · Cited by 34
Reyes, B. A. S., Szot, P., Sikkema, C. L., Cathel, A. M., Kirby, L. G., & Bockstaele, E. J. V. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.016 · Cited by 35
Zhang, G., Chen, W., Lao, L., & Marvizón, J. C. G. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07075.x · Cited by 35
Mitchell, V. A., Kawahara, H., & Vaughan, C. W. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.167429 · Cited by 34
Lau, B. K., Drew, G. M., Mitchell, V. A., & Vaughan, C. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12839 · Cited by 35
Ortiz, J. P., Heinricher, M. M., & Selden, N. R. W. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.003 · Cited by 33
Minkkilä, A., Myllymäki, M. J., Saario, S. M., Castillo‐Melendez, J. A., Koskinen, A. M. P., Fowler, C. J., Leppänen, J., & Nevalainen, T. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.01.007 · Cited by 33
A Fluorescence-Based Assay for Monoacylglycerol Lipase Compatible with Inhibitor Screening
Wang, Y., Chanda, P. K., JONES, P. G., & Kennedy, J. D. (2008) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.122 · Cited by 33
Effects of acute stressors on itch- and pain-related behaviors in rats
Spradley, J. M., Davoodi, A., Carstens, M. I., & Carstens, E. E. (2012) · Pain · doi:10.1016/j.pain.2012.05.032 · Cited by 33
Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters
Fogaça, M. V., Lisboa, S. F. D. S., de Aguiar, D. C., Moreira, F. A., Gomes, F. V., Casarotto, P. C., & Guimarães, F. S. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500029 · Cited by 32
Involvement of glycine receptor α1 subunits in cannabinoid-induced analgesia
Lu, J.-P., Fan, S., Zou, G., Hou, Y., Pan, T., Guo, W., Yao, L., Du, F., Homanics, G. E., Liu, D., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.041 · Cited by 32
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
Thompson, A. L., Grenald, S. A., Ciccone, H. A., Bassirirad, N. M., Niphakis, M. J., Cravatt, B. F., Largent‐Milnes, T. M., & Vanderah, T. W. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.262337 · Cited by 33
Suplita, R. L., Eisenstein, S. A., Neely, M. H., Moise, A. M., & Hohmann, A. G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.006 · Cited by 33
Self-citationThe role of hypothalamo-hypophyseal-adrenocortical system hormones in controlling pain sensitivity
Yarushkina, N. I. (2008) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-008-9044-z · Cited by 32
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 32
Sosa, R. (2022) · Psychological Review · doi:10.1037/rev0000405 · Cited by 31
Ma, W.-X., Yu, T.-S., Fan, Y., Zhang, S., Ren, P., Wang, S.-B., Zhao, R., Pi, J., & Guan, D.-W. (2011) · International Journal of Legal Medicine · doi:10.1007/s00414-011-0567-4 · Cited by 31
Functional role of cannabinoid receptors in urinary bladder
Tyagi, P., Tyagi, V., Yoshimura, N., & Chancellor, M. B. (2010) · Indian Journal of Urology · doi:10.4103/0970-1591.60440 · Cited by 31
Yuan, S., & Burrell, B. D. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00170.2013 · Cited by 31
Yuan, S., & Burrell, B. D. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3922-12.2013 · Cited by 31
Stuart, J. M., Paris, J. J., Frye, C. A., & Bradshaw, H. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/436252 · Cited by 31
In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission
Degroot, A., & Nomikos, G. G. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.001 · Cited by 31
Sachser, R. M., Crestani, A. P., Quillfeldt, J. A., Souza, T. M. E., & Alvares, L. D. O. (2015) · Learning & Memory · doi:10.1101/lm.039891.115 · Cited by 36
Wise, L. E., Harloe, J. P., & Lichtman, A. H. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.06.001 · Cited by 31
The endocannabinoid system in migraine: from bench to pharmacy and back
Tassorelli, C., Greco, R., & Silberstein, S. D. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000688 · Cited by 32
Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500004 · Cited by 34
Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects
Ward, S. J., Lichtman, A. H., Piomelli, D., & Parker, L. A. (2021) · JNCI Monographs · doi:10.1093/jncimonographs/lgab007 · Cited by 29
Self-citationJennings, E. M., Okine, B. N., Olango, W. M., Roche, M., & Finn, D. P. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.008 · Cited by 29
Lisboa, S. F. D. S., Magesto, A. C., Aguiar, J. C. D., Resstel, L. B. M., & Guimarães, F. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.008 · Cited by 29
Roche, M., Johnston, P., Mhuircheartaigh, O. N., Olango, W. M., Mackie, K., & Finn, D. P. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.08.009 · Cited by 29
The Role of The Rostral Ventromedial Medulla in Stress Responses
Pagliusi, M., & Gomes, F. V. (2023) · Brain Sciences · doi:10.3390/brainsci13050776 · Cited by 28
When orexins meet cannabinoids: Bidirectional functional interactions
Berrendero, F., Flores, Á., & Robledo, P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.040 · Cited by 28
Li, P., Zhang, Y., Zhang, Y., Jiang, W., Wang, Y., Zhang, Y.-S., Sun, Z.-Z., Li, C., Zhang, Y., Shi, M., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00009 · Cited by 28
Metadata
- Authors
- Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D.
- Affiliations
- University of Georgia (US)
- University of California, Irvine (US)
- Brown University (US)
- University of Urbino (IT)
- University of Parma (IT)
- Corresponding author
- Hohmann, Andrea G.
- Piomelli, Daniele
- ORCID
- Venue
- Nature
- Published
- 2005-06
- Volume
- 435
- Issue
- 7045
- Pages
- 1108-1112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2030777873
- Cited by
- 778
- References
- 30
- Citations by year
- 2026: 14 · 2025: 24 · 2024: 22 · 2023: 22 · 2022: 28 · 2021: 26 · 2020: 22 · 2019: 20 · 2018: 29 · 2017: 53 · 2016: 34 · 2015: 38 · 2014: 40 · 2013: 33 · 2012: 45
- FWCI
- 39.98
- Type
- journal article
- Language
- en
- Open access
- green
- escholarship.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- stress-induced analgesia, endocannabinoid system, CB1 receptor, periaqueductal gray, 2-arachidonoylglycerol, anandamide, monoacylglycerol lipase, fatty acid amide hydrolase, opioid-independent analgesia, pain inhibition, stress-related disorders, therapeutic target
- MeSH terms
- Analgesia, Animals, Arachidonic Acids, Biological Transport, Biphenyl Compounds, Glycerides, Hydrolysis, Male, Mesencephalon, Monoacylglycerol Lipases, Stress, Physiological, Rats, Sprague-Dawley, Rats, Wistar, Receptor, Cannabinoid, CB1, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review